Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist with well-established research and clinical profiles. It works by mimicking the natural GLP-1 hormone, leading to enhanced glucose-dependent insulin secretion, suppressed glucagon release, slowed gastric emptying, and promoted satiety in the brain. Its applications are extensively studied for supporting healthy blood sugar metabolism and facilitating significant, sustainable weight management through appetite regulation.